Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 1

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Invokana (canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe

NCT01186588: A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function

Completed

Canagliflozin

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Healthy, Hepatic Insufficiency

04/11

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites